238 related articles for article (PubMed ID: 28594301)
21. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
22. Sneddon's syndrome with optic disc macroaneurysm and macular edema successfully treated with subtenon steroid injection.
Nagai N; Ohta Y; Izumi-Nagai K; Shinoda H; Tsubota K; Ozawa Y
Acta Ophthalmol; 2016 Sep; 94(6):e517-9. PubMed ID: 26612193
[No Abstract] [Full Text] [Related]
23. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
24. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
Bakri SJ; Kaiser PK
Am J Ophthalmol; 2005 Feb; 139(2):290-4. PubMed ID: 15733990
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema.
Yalcinbayir O; Gelisken O; Kaderli B; Avci R
Ophthalmologica; 2011; 225(4):222-7. PubMed ID: 21389739
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion.
Moon J; Kim M; Sagong M
Eye (Lond); 2016 Aug; 30(8):1084-90. PubMed ID: 27229707
[TBL] [Abstract][Full Text] [Related]
27. Orbital abscess caused by Exophiala dermatitidis following posterior subtenon injection of triamcinolone acetonide: a case report and a review of literature related to Exophiala eye infections.
Iwahashi C; Eguchi H; Hotta F; Uezumi M; Sawa M; Kimura M; Yaguchi T; Kusaka S
BMC Infect Dis; 2020 Aug; 20(1):566. PubMed ID: 32746887
[TBL] [Abstract][Full Text] [Related]
28. Sub-tenon triamcinolone acetonide injections for topical medication intolerance in chronic blepharokeratoconjunctivitis.
Bondalapati S; Cabrera MT
Cornea; 2014 Sep; 33(9):999-1001. PubMed ID: 25014152
[TBL] [Abstract][Full Text] [Related]
29. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
Shimura M; Yasuda K; Minezaki T; Noma H
Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis.
McKay KM; Borkar DS; Sevgi DD; Susarla G; Papaliodis GN; Sobrin L
Ocul Immunol Inflamm; 2021 Jul; 29(5):857-864. PubMed ID: 31902274
[No Abstract] [Full Text] [Related]
31. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
Iwao K; Inatani M; Kawaji T; Koga T; Mawatari Y; Tanihara H
J Glaucoma; 2007 Mar; 16(2):251-6. PubMed ID: 17473740
[TBL] [Abstract][Full Text] [Related]
32. Effect of posterior subtenon injection of 40 mg of triamcinolone acetonide on glycemic control and serum cortisol and adrenocorticotropic hormone in diabetic patients.
Kaderli B; Kivanc SA; Inan UU; Ersoy C; Yucel AA; Yilmaz S; Avci R
Eur Rev Med Pharmacol Sci; 2014; 18(18):2609-14. PubMed ID: 25317793
[TBL] [Abstract][Full Text] [Related]
33. Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application.
Shen L; You Y; Sun S; Chen Y; Qu J; Cheng L
Ophthalmology; 2010 Dec; 117(12):2365-71. PubMed ID: 20678801
[TBL] [Abstract][Full Text] [Related]
34. Localised abscess following an injection of subtenon triamcinolone acitonide.
Azarbod P; Mohammed Q; Akram I; Moorman C
Eye (Lond); 2007 May; 21(5):672-4. PubMed ID: 17173012
[No Abstract] [Full Text] [Related]
35. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
Salti H; Farah T
Am J Ophthalmol; 2005 Nov; 140(5):958; author reply 958-9. PubMed ID: 16310498
[No Abstract] [Full Text] [Related]
36. Comparison of the efficacy and safety of different methods of posterior subtenon injection.
Venkatesh P; Kumar CS; Abbas Z; Garg S
Ocul Immunol Inflamm; 2008; 16(5):217-23. PubMed ID: 19065416
[TBL] [Abstract][Full Text] [Related]
37. Role of oral corticosteroids in orbital cellulitis.
Pushker N; Tejwani LK; Bajaj MS; Khurana S; Velpandian T; Chandra M
Am J Ophthalmol; 2013 Jul; 156(1):178-183.e1. PubMed ID: 23622565
[TBL] [Abstract][Full Text] [Related]
38. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
[TBL] [Abstract][Full Text] [Related]
39. Periocular injections of triamcinolone for sympathetic ophthalmia.
Sandinha MT; Lake S
Clin Exp Ophthalmol; 2010 Nov; 38(8):819-21. PubMed ID: 20572826
[No Abstract] [Full Text] [Related]
40. Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide.
Kawamura R; Inoue M; Shinoda H; Shinoda K; Itoh Y; Ishida S; Tsubota K
J Ocul Pharmacol Ther; 2011 Jun; 27(3):299-304. PubMed ID: 21510808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
